December 21, 2011 – Autism Therapeutics Announces Purchase of Neuropharm Ltd.

Posted by on Dec 21, 2011 in Press Release | 0 comments

Autism Therapeutics announced today the purchase of Neuropharm Ltd. This follows the liquidation of the UK holding of the previously publicly listed company Neuropharm PLC, which occurred in mid 2010. Neuropharm holds intellectual property relating to the ZYDIS™ ODT Fluoxetine / Autism program for autism, which has received Orphan Drug Designation in the U.S.

AT Press Release December 21 2011 (Neuropharm Acquisition)